AiTEM, the AI formulation innovation platform developed by AiTEM Therapeutics, has completed its localized deployment at Hengrui Medicine and signed a strategic cooperation agreement with Zhejiang Hisun Pharmaceutical.
AiTEM, AIT Therapeutics' AI-powered formulation innovation platform, completed its on-premise deployment at Hengrui Pharmaceuticals on August 3rd, to be used for the development of formulations for poorly soluble drugs. Furthermore, after the reporting period, the company also signed a strategic cooperation agreement with Zhejiang Hisun Pharmaceutical Co., Ltd., further expanding its AI platform's on-premise deployment collaborations with pharmaceutical companies.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Regulatory Landscape of Virtual Currencies in Mainland China and Risks Associated with Using Overseas Trading Platforms
-
2
SKR Tokenomics Analysis: The Core Driver of the Solana Mobile Ecosystem
-
3
According to Bloomberg Markets: Large asset managers are deleveraging in the U.S. Treasury futures market, triggered by forced selling as cash yields approach multi-year highs.
-
4
Wall Street's Rate Shock Spreads Beneath AI-Fueled Market Rally, Driven by High Oil Prices and Borrowing Costs
-
5
iPhone Vulnerabilities Continue to Threaten Crypto Users, Older iOS Devices Remain at Risk
-
6
TypeSafe AI, the maker of the non-text AI model Jev, reached a valuation of $7.5 billion just weeks after its launch, with a16z leading an $870 million funding round.
-
7
Hungary Needs Significant Deficit Cut For Euro Path, Magyar Says
-
8
Base Network: Coinbase's Layer 2 Solution and Its Ecosystem Development Status
-
9
Binance founder CZ warns of potential supply chain attack on Ledger hardware wallets, calls on BNB ecosystem to help recover funds.
-
10
Neo (Antcoin) In-depth Analysis: The Technical Evolution and Ecosystem Layout of "China's Ethereum"
Markets Today
Recommended Reading






